🇺🇸 Fumaderm in United States

106 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Psoriasis — 15 reports (14.15%)
  2. Diarrhoea — 14 reports (13.21%)
  3. General Physical Health Deterioration — 14 reports (13.21%)
  4. Nausea — 11 reports (10.38%)
  5. Anaemia — 10 reports (9.43%)
  6. Drug Intolerance — 9 reports (8.49%)
  7. Liver Function Test Increased — 9 reports (8.49%)
  8. Abdominal Pain — 8 reports (7.55%)
  9. Colitis — 8 reports (7.55%)
  10. Colitis Microscopic — 8 reports (7.55%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Fumaderm approved in United States?

Fumaderm does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fumaderm in United States?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.